Advertisement
UK markets closed
  • FTSE 100

    8,317.59
    -21.64 (-0.26%)
     
  • FTSE 250

    20,770.93
    +139.63 (+0.68%)
     
  • AIM

    810.02
    +5.00 (+0.62%)
     
  • GBP/EUR

    1.1737
    +0.0000 (+0.00%)
     
  • GBP/USD

    1.2739
    +0.0041 (+0.32%)
     
  • Bitcoin GBP

    53,949.61
    +910.15 (+1.72%)
     
  • CMC Crypto 200

    1,445.18
    -22.92 (-1.56%)
     
  • S&P 500

    5,304.72
    +36.88 (+0.70%)
     
  • DOW

    39,069.59
    +4.33 (+0.01%)
     
  • CRUDE OIL

    77.80
    +0.93 (+1.21%)
     
  • GOLD FUTURES

    2,335.20
    -2.00 (-0.09%)
     
  • NIKKEI 225

    38,646.11
    -457.11 (-1.17%)
     
  • HANG SENG

    18,608.94
    -259.77 (-1.38%)
     
  • DAX

    18,693.37
    +2.05 (+0.01%)
     
  • CAC 40

    8,094.97
    -7.36 (-0.09%)
     

New Strong Sell Stocks for February 27th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Altice USA ATUS is a provider of broadband communications and video services in the United States, Canada, Puerto Rico, and the Virgin Islands. The Zacks Consensus Estimate for its current year earnings has been revised 50.7% downward over the last 60 days.

Calliditas Therapeutics CALT is a specialty pharmaceutical company which is focused on developing pharmaceutical products for patients with a significant unmet medical need. The Zacks Consensus Estimate for its current year earnings has been revised 29.5% downward over the last 60 days.

California Resources CRC is an exploration and production company as well as producer of oil and natural gas principally in California. The Zacks Consensus Estimate for its current year earnings has been revised almost 16.0% downward over the last 60 days.

ADVERTISEMENT

View the entire Zacks Rank #5 List.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

California Resources Corporation (CRC) : Free Stock Analysis Report

Altice USA, Inc. (ATUS) : Free Stock Analysis Report

Calliditas Therapeutics AB Sponsored ADR (CALT) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research